WAT
57
3
VTR
35
3
KR
46
-3
HBAN
54
3
CNP
49
2
TRV
42
3
LMT
40
13
PRU
45
5
CHRW
56
5
EBAY
40
-2
R
56
2
KLAC
56
8
DG
29
12
UNH
44
6
SBUX
48
13
AFL
32
2
ROP
33
-2
EXR
30
6
CCL
46
-4
LH
39
3
WAT
57
3
VTR
35
3
KR
46
-3
HBAN
54
3
CNP
49
2
TRV
42
3
LMT
40
13
PRU
45
5
CHRW
56
5
EBAY
40
-2
R
56
2
KLAC
56
8
DG
29
12
UNH
44
6
SBUX
48
13
AFL
32
2
ROP
33
-2
EXR
30
6
CCL
46
-4
LH
39
3
Financhill
Back

BridgeBio Pharma Stock Predictions

Stock Caught Trading Under Secret Name...

Find out more about the "hidden stock" here.
Sell
42

BBIO
BridgeBio Pharma

Last Price:
$28.13
Seasonality Move:
2.36%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

BridgeBio Pharma Stock Forecast

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 74% based on the past 5 years of stock performance.
  • BridgeBio Pharma has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is BridgeBio Pharma Stock Undervalued?
    The current BridgeBio Pharma [BBIO] share price is $28.12. The Score for BBIO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • BBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will BridgeBio Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 74% based on the past 5 years of stock performance.

BridgeBio Pharma Stock Rating

Sell
42
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma overpriced?

  • BridgeBio Pharma has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

BridgeBio Pharma Stock Price History

Is BBIO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com

52-Week Data

52-Week High:
41.04
52-Week Low:
21.62

Prediction Charts

Market Cap:
5.3B
Price in USD:
28.12
Volume:
1.3M
Beta:
1.08

Technical Analysis

SMA50:
26.12
SMA100:
26.06
SMA200:
26.62
52-Wk Change:
-25.71%

Stock Predictions

  • Is BridgeBio Pharma stock public?
    Yes, BridgeBio Pharma is a publicly traded company.
  • What is the BridgeBio Pharma stock quote today?
    The BridgeBio Pharma stock price is 28.12 USD today.
  • How to buy BridgeBio Pharma stock online?
    You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-13 27.68 27.49 28.28 27.00
Dec-16 27.69 27.71 28.18 27.42
Dec-17 27.43 27.82 27.98 27.17
Dec-18 27.88 25.99 28.15 25.51
Dec-19 26.08 26.21 26.61 25.34
Dec-20 26.04 26.50 26.90 26.02
Dec-23 26.75 27.77 27.79 26.55
Dec-24 27.76 28.53 28.59 27.56
Dec-26 28.18 28.39 28.84 27.78
Dec-27 28.17 27.99 28.82 27.60
Dec-30 27.90 27.32 27.99 27.23
Dec-31 27.50 27.44 27.89 27.32
Jan-2 27.79 28.20 29.00 27.53
Jan-3 28.16 28.12 28.56 27.79

BridgeBio Pharma Earnings

BridgeBio Pharma Earnings Report: Per Share BridgeBio Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

BridgeBio Pharma Forecast Revenue Growth

BridgeBio Pharma Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.07 per share, and an increase next year of $0.52 per share.

* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.